Showing results (241-250 of 586) with videos related to
Sort By:
Pageof 59
Blood Coagulation & Fibrinolysis : an International Journal in Haemostasis and Thrombosis|June 10, 2000
Clinical and laboratory expression of associated thrombophilic conditions (homozygous/heterozygous factor V Leiden mutation and heterozygous prothrombin variant 20210A) in an Italian familyP Simioni, D Tormene, S Luni, et al.Haemophilia : the Official Journal of the World Federation of Hemophilia|September 30, 2000
Proposal of a standard approach to dental extraction in haemophilia patients. A case-control study with good resultsE Zanon, F Martinelli, C Bacci, et al.Clinical and Applied Thrombosis/Hemostasis : Official Journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis|November 8, 2001
Hemophilia A, von Willebrand disease, and atherosclerosis of abdominal aorta and leg arteries: factor VIII and von Willebrand factor defects appear to protect abdominal aorta and leg arteries from atherosclerosisF Bilora, V Boccioletti, E Zanon, et al.La Clinica Terapeutica|May 31, 1989
[Erythrocyte filterability and relative viscosity in liver cirrhosis and chronic hepatitis]M Mares, I Visentin, P Radossi, et al.The Journal of Clinical Investigation|April 1, 1985
Interaction of asialo von Willebrand factor with glycoprotein Ib induces fibrinogen binding to the glycoprotein IIb/IIIa complex and mediates platelet aggregationL De Marco, A Girolami, S Russell, et al.Thrombosis and Haemostasis|August 13, 1990
1-Desamino-8-D-arginine vasopressin (DDAVP) infusion in type IIB von Willebrand's disease: shortening of bleeding time and induction of a variable pseudothrombocytopeniaA Casonato, M T Sartori, L de Marco, et al.Haematologica|May 1, 1990
Chronic B-cell lymphoproliferative disease: relationship between immunophenotype and clinical stageF Dazzi, A Veronesi, E D'Andrea, et al.Laboratory Hematology : Official Publication of the International Society for Laboratory Hematology|June 28, 2011
Similarities and discrepancies in homozygous factor VII defects due to mutations in the region of residues Met298 to Cys310 (exon 8) in the catalytic domain of factor VIIA Girolami, G Berti de Marinis, E Bonamigo, et al.American Journal of Clinical Pathology|March 1, 1984
The role of laser nephelometer in the study of abnormal clotting factors: characterization of two abnormal antithrombins (AT III Padua and AT III Padua2)A Girolami, G Ruzza, L Saggin, et al.Blood Coagulation & Fibrinolysis : an International Journal in Haemostasis and Thrombosis|June 5, 1999
Frequent but low titre factor VIII inhibitors in haemophilia A patients treated with high purity concentratesE Zanon, P Zerbinati, B Girolami, et al.Pageof 59